These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36735409)

  • 1. Reconsidering Race Adjustment in Prenatal Alpha-Fetoprotein Screening.
    Burns RN; Kolarova T; Katz R; Ma K; Delaney S
    Obstet Gynecol; 2023 Mar; 141(3):438-444. PubMed ID: 36735409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Maternal Race and Weight Provides Equitable Performance in Serum Screening for Open Neural Tube Defects.
    Messerlian G; Strickland SW; Willbur J; Vaughan C; Koenig S; Wright T; Palomaki GE
    Clin Chem; 2024 Jul; 70(7):948-956. PubMed ID: 38965696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-fetoprotein concentrations in maternal serum: relation to race and body weight.
    Crandall BF; Lebherz TB; Schroth PC; Matsumoto M
    Clin Chem; 1983 Mar; 29(3):531-3. PubMed ID: 6186415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?
    Sancken U; Bartels I
    Prenat Diagn; 2001 May; 21(5):383-6. PubMed ID: 11360279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Screening for chromosomal anomalies with maternal serum alpha-fetoprotein].
    Shintaku Y; Takabayashi T; Sasaki H; Ozawa N; Shinkawa O; Hamazaki Y; Yajima A
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):185-90. PubMed ID: 2470844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight.
    Wald NJ; Cuckle HS; Densem JW; Kennard A; Smith D
    Br J Obstet Gynaecol; 1992 Feb; 99(2):144-9. PubMed ID: 1372820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First and second trimester maternal serum markers for prenatal aneuploidy screening: An update on the adjustment factors for race, smoking, and insulin dependent diabetes mellitus.
    Huang T; Bellai-Dussault K; Meng L; Hull D; Howley H; Reszel J; Lanes A; Walker M; Armour CM; Okun N; Dougan SD
    Clin Biochem; 2023 Aug; 118():110596. PubMed ID: 37295638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down syndrome screening in an Asian population using alpha-fetoprotein and free beta-hCG: a report of the Taiwan Down Syndrome Screening Group.
    Hsu JJ; Hsieh TT; Hsieh FJ
    Obstet Gynecol; 1996 Jun; 87(6):943-7. PubMed ID: 8649703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum alpha-fetoprotein in the three trimesters of pregnancy: effects of maternal characteristics and medical history.
    Bredaki FE; Sciorio C; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Jul; 46(1):34-41. PubMed ID: 25652769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significant effects on alpha-fetoprotein (AFP) concentration in maternal serum in pregnancy].
    Greiff R; Schlosser H; Amse T
    Zentralbl Gynakol; 1991; 113(5):253-7. PubMed ID: 1711749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between maternal hepatitis B virus carrier status and Down's syndrome prenatal screening indicators and their effects on the screening results.
    Huang L; Chen Y; Ning W; Chen Y; Yu D
    J Obstet Gynaecol; 2022 Oct; 42(7):2793-2798. PubMed ID: 36036240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal smoking: age distribution, levels of alpha-fetoprotein and human chorionic gonadotrophin, and effect on detection of Down syndrome pregnancies in second-trimester screening.
    Crossley JA; Aitken DA; Waugh SM; Kelly T; Connor JM
    Prenat Diagn; 2002 Mar; 22(3):247-55. PubMed ID: 11920904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of second-trimester maternal serum free-beta-human chorionic gonadotropin and alpha-fetoprotein between normal singleton and twin pregnancies: a population-based study.
    Zheng MM; Hu YL; Zhang CY; Ru T; Liu QL; Xu BY; Chen QG; Xu ZF; Zhang Y; Zhong XL
    Chin Med J (Engl); 2010 Mar; 123(5):555-8. PubMed ID: 20367980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal serum alpha-fetoprotein and fetal trisomy-21 in women 35 years and older: implications for alpha-fetoprotein screening programs.
    Ashwood ER; Cheng E; Luthy DA
    Am J Med Genet; 1987 Mar; 26(3):531-9. PubMed ID: 2436476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of maternal serum alpha-fetoprotein and free beta human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screening.
    Berry E; Aitken DA; Crossley JA; Macri JN; Connor JM
    Prenat Diagn; 1995 Jun; 15(6):555-65. PubMed ID: 7544898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lens culinaris agglutinin-reactive alpha-fetoprotein, an alternative variant to alpha-fetoprotein in prenatal screening for Down's syndrome.
    Yamamoto R; Azuma M; Hoshi N; Kishida T; Satomura S; Fujimoto S
    Hum Reprod; 2001 Nov; 16(11):2438-44. PubMed ID: 11679535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of allowing for ethnic group in prenatal screening for Down's syndrome.
    Watt HC; Wald NJ; Smith D; Kennard A; Densem J
    Prenat Diagn; 1996 Aug; 16(8):691-8. PubMed ID: 8878277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal diagnosis of neural tube defects. VIII. The importance of serum alpha-fetoprotein screening in diabetic pregnant women.
    Milunsky A; Alpert E; Kitzmiller JL; Younger MD; Neff RK
    Am J Obstet Gynecol; 1982 Apr; 142(8):1030-2. PubMed ID: 6176126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.